| Joshua A Boggs, MD | |
|
497 Mall Rd, Oak Hill, WV 25901-6216 | |
| (044) 692-9053 | |
| Not Available |
| Full Name | Joshua A Boggs |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 497 Mall Rd, Oak Hill, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477873941 | NPI | - | NPPES |
| 3810026438 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 25161 (West Virginia) | Primary |
| 207QA0505X | Family Medicine - Adult Medicine | 25161 (West Virginia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Of West Virginia | Charleston, WV | Home health agency |
| Kindred At Home | Beckley, WV | Home health agency |
| Plateau Medical Center | Oak hill, WV | Hospital |
| Summersville Regional Medical Center | Summersville, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New River Health Association Inc | 2365348596 | 29 |
News Archive
Adynxx, developer of a first-in-class platform of therapeutics to address pain at its molecular roots, announced today that the first patient was dosed in ADYX-003, a Phase 2 dose-ranging study of AYX1, an investigational drug candidate for the prevention of post-surgical pain.
With flu season in full swing and the threat of H1N1 looming, demand for vaccines is at an all-time high. Although those vaccines are expected to be effective, University of Missouri researchers have found further evidence that some over-the-counter drugs, such as aspirin and Tylenol, that inhibit certain enzymes could impact the effectiveness of vaccines.
Metabolically healthy obese adults consuming a diet high in unsaturated fat and low in saturated fat may be able to decrease their total cholesterol by 10 points, a new study suggests.
Akorn, Inc., a niche generic pharmaceutical company, today reported that its Akorn-Strides LLC joint venture has entered into a purchase agreement with Pfizer Inc. to sell 16 Abbreviated New Drug Approvals (ANDAs) and 6 filed ANDAs. For its portion, Akorn, Inc. will receive $35 million in cash. Akorn-Strides LLC will continue to manufacture and distribute the approved products until April 30, 2011.
Discovery of a new mechanism of drug action could lead to the next generation of drugs to treat schizophrenia.
› Verified 2 days ago
| Entity Name | New River Health Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407394646 PECOS PAC ID: 2365348596 Enrollment ID: O20170731000918 |
News Archive
Adynxx, developer of a first-in-class platform of therapeutics to address pain at its molecular roots, announced today that the first patient was dosed in ADYX-003, a Phase 2 dose-ranging study of AYX1, an investigational drug candidate for the prevention of post-surgical pain.
With flu season in full swing and the threat of H1N1 looming, demand for vaccines is at an all-time high. Although those vaccines are expected to be effective, University of Missouri researchers have found further evidence that some over-the-counter drugs, such as aspirin and Tylenol, that inhibit certain enzymes could impact the effectiveness of vaccines.
Metabolically healthy obese adults consuming a diet high in unsaturated fat and low in saturated fat may be able to decrease their total cholesterol by 10 points, a new study suggests.
Akorn, Inc., a niche generic pharmaceutical company, today reported that its Akorn-Strides LLC joint venture has entered into a purchase agreement with Pfizer Inc. to sell 16 Abbreviated New Drug Approvals (ANDAs) and 6 filed ANDAs. For its portion, Akorn, Inc. will receive $35 million in cash. Akorn-Strides LLC will continue to manufacture and distribute the approved products until April 30, 2011.
Discovery of a new mechanism of drug action could lead to the next generation of drugs to treat schizophrenia.
› Verified 2 days ago
| Entity Name | New River Health Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386318756 PECOS PAC ID: 2365348596 Enrollment ID: O20210903001544 |
News Archive
Adynxx, developer of a first-in-class platform of therapeutics to address pain at its molecular roots, announced today that the first patient was dosed in ADYX-003, a Phase 2 dose-ranging study of AYX1, an investigational drug candidate for the prevention of post-surgical pain.
With flu season in full swing and the threat of H1N1 looming, demand for vaccines is at an all-time high. Although those vaccines are expected to be effective, University of Missouri researchers have found further evidence that some over-the-counter drugs, such as aspirin and Tylenol, that inhibit certain enzymes could impact the effectiveness of vaccines.
Metabolically healthy obese adults consuming a diet high in unsaturated fat and low in saturated fat may be able to decrease their total cholesterol by 10 points, a new study suggests.
Akorn, Inc., a niche generic pharmaceutical company, today reported that its Akorn-Strides LLC joint venture has entered into a purchase agreement with Pfizer Inc. to sell 16 Abbreviated New Drug Approvals (ANDAs) and 6 filed ANDAs. For its portion, Akorn, Inc. will receive $35 million in cash. Akorn-Strides LLC will continue to manufacture and distribute the approved products until April 30, 2011.
Discovery of a new mechanism of drug action could lead to the next generation of drugs to treat schizophrenia.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joshua A Boggs, MD 497 Mall Rd, Oak Hill, WV 25901-6216 Ph: (304) 469-2905 | Joshua A Boggs, MD 497 Mall Rd, Oak Hill, WV 25901-6216 Ph: (044) 692-9053 |
News Archive
Adynxx, developer of a first-in-class platform of therapeutics to address pain at its molecular roots, announced today that the first patient was dosed in ADYX-003, a Phase 2 dose-ranging study of AYX1, an investigational drug candidate for the prevention of post-surgical pain.
With flu season in full swing and the threat of H1N1 looming, demand for vaccines is at an all-time high. Although those vaccines are expected to be effective, University of Missouri researchers have found further evidence that some over-the-counter drugs, such as aspirin and Tylenol, that inhibit certain enzymes could impact the effectiveness of vaccines.
Metabolically healthy obese adults consuming a diet high in unsaturated fat and low in saturated fat may be able to decrease their total cholesterol by 10 points, a new study suggests.
Akorn, Inc., a niche generic pharmaceutical company, today reported that its Akorn-Strides LLC joint venture has entered into a purchase agreement with Pfizer Inc. to sell 16 Abbreviated New Drug Approvals (ANDAs) and 6 filed ANDAs. For its portion, Akorn, Inc. will receive $35 million in cash. Akorn-Strides LLC will continue to manufacture and distribute the approved products until April 30, 2011.
Discovery of a new mechanism of drug action could lead to the next generation of drugs to treat schizophrenia.
› Verified 2 days ago
Fred L Akerberg, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 497 Mall Rd, Oak Hill, WV 25901 Phone: 304-469-2905 Fax: 304-465-1518 | |
Dr. Lora Habib Keaveny, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 119 Main St W, Suite A, Oak Hill, WV 25901 Phone: 304-465-0544 Fax: 304-465-8832 | |
Mohammad Anwar Ullah, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 435 Main St W, Oak Hill, WV 25901 Phone: 304-465-5066 Fax: 304-465-5066 | |
Serafino S Maducdoc, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 320 Jones Avenue, Oak Hill, WV 25901 Phone: 304-469-2500 Fax: 304-469-3399 | |
Joseph Ivan Golden, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 497 Mall Rd, Oak Hill, WV 25901 Phone: 304-469-2905 Fax: 304-465-5486 | |
Richard A Spencer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 497 Mall Rd, Oak Hill, WV 25901 Phone: 304-469-2905 Fax: 304-469-5486 |